Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution	Test outcome NA N A AA L LL H HH
3032390	u-jcvnh	— (—)	214	893	100.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

Chronic kidney disease

149

111.22

280.85

4.7

2.3

—

L04AA Selective immunosuppressants

143

90.57

272.95

4.3

2.8

—

Renal failure

155

82.96

253.42

4.6

2.6

—

All chronic kidney diseases

159

55.36

231.79

4.7

3.3

—

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

179

62.96

216.21

4.3

1.7

—

All kidney diseases

168

31.32

188.75

4.6

2.6

—

ILD medications: immunosuppressive drugs

199

226.45

186.14

4.4

1.0

—

L04AD Calcineurin inhibitors

185

323.66

183.54

4.4

6.8

—

Renal tubulo-interstitial diseases

156

26.63

180.33

4.4

3.2

—

Glomerular diseases

101

42.59

168.78

4.8

—

First line medication for Crohn's disease

161

48.19

162.48

5.1

2.0

—

Nephropathy related operations

158

232.66

154.00

4.8

2.7

—

Kidney transplant status

152

233.79

149.11

4.8

2.7

—

Dialysis, with operation codes

150

220.17

145.68

4.6

2.7

—

Extracorporeal dialysis

78.42

141.91

4.1

4.9

—

Azathioprine

33.46

134.76

6.2

3.8

—

ILD medications

176

105.57

127.70

4.8

1.0

—

ILD medications: prednisolone, methylprednisolone, prednisone

170

118.32

126.13

4.7

1.0

—

Hypoplasia of dental enamel

48.05

119.15

7.7

6.1

—

Molar incisor enamel hypoplasia

31.24

114.87

7.6

5.9

—

Glomerulonephritis

39.52

114.60

6.1

5.5

—

L04AX Other immunosuppressants

101

14.88

114.08

5.8

2.6

—

Fever of other and unknown origin

20.92

113.30

3.8

2.2

—

Second line medication for Crohn's disease

102

14.19

112.19

5.8

2.5

—

Acute tubulo-interstitial nephritis

24.80

110.71

4.4

3.2

—

Care involving dialysis

116

150.05

109.86

4.3

4.1

—

Hypoplasia of dental enamel , including avohilmo

30.24

109.79

7.7

6.1

—

Persons encountering health services for specific procedures and health care

138

14.06

107.84

4.2

3.9

—

Gingival hyperplasia

51.18

102.11

7.4

6.0

—

Nephrotic syndrome

50.70

100.09

6.9

7.2

—

Dialysis

100

177.75

96.40

5.4

2.5

—

Septicaemia

16.10

90.02

4.8

4.5

—

Other septicaemia

17.53

89.88

4.5

4.7

—

Other septicaemia, including avohilmo

17.45

89.41

4.5

4.7

—

Explicit Sepsis

15.74

88.97

4.8

4.6

—

Explicit Sepsis, including avohilmo

15.33

87.56

4.8

4.5

—

Diarrhoea and gastroenteritis of presumed infectious origin

11.44

87.26

5.2

2.6

—

Antihypertensive medication - note that there are other indications

109

18.41

86.50

6.0

3.1

—

Hypertensive diseases (excluding secondary)

19.51

85.21

5.8

3.8

—

Other bacterial diseases

120

10.07

84.86

4.4

3.8

—

Intestinal infectious diseases

111

9.83

82.70

4.6

2.5

—

Other disorders of kidney and ureter

38.79

81.37

4.7

4.5

—

Secondary hypertension

139.23

77.77

4.6

4.8

—

Other bacterial diseases, including avohilmo

121

9.00

76.98

4.4

3.9

—

Hypertensive diseases

104

13.05

76.22

5.5

3.1

—

Hypertension

104

13.05

76.20

5.5

3.1

—

Bacterial infection, other or unspecified

14.35

72.96

3.9

3.5

—

Other problems related to primary support group, including family circumstances

15.88

72.17

7.8

4.5

—

Viral and other specified intestinal infections

15.59

70.64

6.3

3.7

—

Dental caries

84.37

70.14

3.8

1.3

—

Bacterial infection, other or unspecified, including avohilmo

12.56

68.57

3.9

3.6

—

Cardiovascular diseases (excluding rheumatic etc)

11.23

67.33

5.4

4.6

—

Viral and other specified intestinal infections, including avohilmo

13.82

66.78

6.2

3.6

—

Viral infections characterized by skin and mucous membrane lesions

9.77

66.71

5.0

4.8

—

Congenital malformations of the urinary system

18.04

65.51

4.8

6.8

—

Congenital malformations of the urinary system, including avohilmo

18.01

65.49

4.8

6.8

—

Genitourinary diseases

17.59

63.66

6.4

3.5

—

Cardiovascular diseases

11.37

60.56

5.6

4.8

—

Other dialysis

79.08

59.74

5.5

5.0

—

Heart failure, not strict

11.17

59.21

2.8

4.2

—

Molar incisor enamel hypoplasia, with caries

87.87

58.47

7.4

9.3

—

Implicit viral Sepsis

21.58

57.73

4.2

4.7

—

Viral Sepsis

21.58

57.73

4.2

4.8

—

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

10.41

57.66

7.4

3.6

—

Inflammatory bowel disease treatment related agents

111

6.92

54.90

5.3

2.8

—

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

101

6.74

54.15

4.5

3.7

—

Caries of dentine

75.17

54.09

2.9

1.4

—

Aplastic and other anaemias

12.60

53.72

4.3

3.3

—

Implicit viral Sepsis, including avohilmo

15.34

52.66

4.0

—

Dependence on enabling machines and devices, not elsewhere classified

+∞

52.03

7.0

0.0

—

Primary_lymphoid and hematopoietic malignant neoplasms

14.11

49.29

3.3

5.6

—

Acute upper respiratory infections of multiple and unspecified sites

8.93

49.18

4.2

2.3

—

Any gastric operation

42.41

48.32

4.5

2.9

—

GASTRO-related operations

42.41

48.32

4.5

2.9

—

Other viral diseases

7.61

47.64

5.8

4.6

—

Implicit Sepsis

8.95

47.42

3.4

4.0

—

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

10.35

46.03

4.0

2.0

—

10.35

46.03

4.0

2.0

—

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

116

5.91

44.82

4.2

3.9

—

Certain infectious and parasitic diseases

13.95

44.48

4.2

1.7

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

7.94

44.32

4.6

6.7

—

Implicit bacterial Sepsis

14.76

44.01

3.4

4.0

—

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

7.84

43.92

4.6

6.6

—

Metabolic disorders

6.79

43.78

3.2

4.6

—

Bacterial Sepsis

11.50

43.66

3.9

—

Influenza and pneumonia

102

5.81

43.32

4.0

3.9

—

Liquid cancers

11.86

43.15

3.3

5.3

—

Care involving use of rehabilitation procedures

9.54

42.89

3.9

4.1

—

All influenza

10.03

42.39

5.0

4.9

—

Implicit bacterial Sepsis, including avohilmo

13.57

42.32

3.4

3.8

—

Excessive attrition of teeth

104

6.48

41.74

6.6

2.7

—

Implicit Sepsis, including avohilmo

7.59

41.38

3.4

3.8

—

Other viral diseases, including avohilmo

102

6.52

41.36

5.7

4.3

—

Disorders resulting from impaired renal tubular function

69.27

41.27

4.6

4.7

—

Gastrointestinal diseases

24.58

40.96

4.9

1.2

—

Anaemias

50.55

39.60

5.4

5.6

—

Glomerular disorders in diseases classified elsewhere

57.99

39.29

2.2

3.4

—

Nausea and vomiting

8.07

38.50

5.5

5.3

—

Infections, IBD-co-morbidities

20.07

37.72

3.0

5.4

—

Pneumonia, organism unspecified

5.67

37.57

4.1

3.9

—

Condition for Implicit Sepsis (Organ dysfunction codes)

6.93

37.35

3.4

3.7

—

Liquid cancers, including Hilmo

9.45

36.60

3.3

5.0

—

Other disorders of fluid, electrolyte and acid-base balance

14.58

36.55

3.8

4.1

—

Acute renal failure

60.22

36.12

4.1

1.4

—

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

5.95

35.76

4.5

2.5

—

Congenital malformations, deformations and chromosomal abnormalities

105

5.87

35.68

3.9

4.2

—

Pneumonias (Asthma/COPD co-morbidities)

113

5.03

35.05

4.1

4.2

—

Erosion of teeth , including avohilmo

8.20

34.16

6.4

3.6

—

Other viral diseases, not elsewhere classified

6.95

32.84

6.5

5.1

—

Any reimbursement code in KELA

50.17

32.80

3.9

1.6

—

Disorders of other endocrine glands

5.96

32.75

5.6

5.1

—

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

6.10

32.60

3.4

3.8

—

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

121

4.68

31.96

4.1

4.2

—

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

108

5.40

31.77

3.9

4.0

—

All pneumoniae

121

4.62

31.56

4.1

4.2

—

Provisional assignment of new diseases of uncertain etiology

6.17

29.96

3.8

3.9

—

Codes for special purposes

6.17

29.95

3.8

3.9

—

General examination and investigation of persons without complaint and reported diagnosis

11.69

29.68

5.0

1.5

—

Other and unspecified anaemias

8.69

28.57

4.0

3.3

—

Cystic kidney disease

49.83

28.51

3.4

4.1

—

Cystic kidney disease, including avohilmo

49.73

28.49

3.4

4.1

—

Other anaemias

8.67

28.46

4.0

3.3

—

Bronchitis

5.58

28.42

3.6

2.0

—

Other viral diseases, not elsewhere classified, including avohilmo

5.84

28.35

6.4

4.8

—

Other reaction to severe stress, and adjustment disorders

7.33

28.31

3.6

3.1

—

Diabetic nephropathy

48.17

28.20

1.1

1.4

—

Intestinal infectious diseases, including avohilmo, including avohilmo

5.09

28.16

4.0

2.5

—

Viral warts, including avohilmo

7.43

27.95

5.0

4.4

—

Covid-19 confirmed case

7.50

27.48

3.6

3.2

—

Acute suppurative otitis media

6.88

26.66

5.5

4.2

—

Diabetic nephropathy, excluding more controls

46.36

26.42

1.1

1.3

—

Acute peritonitis

60.64

25.99

4.0

1.0

—

Other cataract

11.53

25.47

4.2

2.9

—

Complications of medical and surgical care

5.55

25.46

2.8

2.9

—

Other retinal disorders

6.82

25.38

1.7

2.9

—

Diseases of peritoneum

50.31

25.23

4.0

2.0

—

Certain disorders involving the immune mechanism

8.88

25.04

5.1

4.1

—

General symptoms and signs

6.05

24.58

3.5

2.0

—

Disorders of ocular muscles, binocular movement, accommodation and refraction

110

4.78

23.69

6.1

4.5

—

Complications of surgical and medical care, not elsewhere classified

4.57

23.19

2.8

3.2

—

Zoster [herpes zoster], including avohilmo

7.30

23.08

2.1

2.4

—

Other disorders of urethra and urinary system

5.95

23.07

4.5

3.3

—

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

6.04

22.93

2.7

2.9

—

Other special examinations and investigations of persons without complaint or reported diagnosis

9.63

22.32

4.2

1.5

—

Hypoplasia of dental enamel, prenatal

50.70

22.19

9.8

5.6

—

Otitis media, unspecified

7.59

21.96

5.3

5.5

—

Viral warts

17.12

21.75

5.5

—

Certain infectious and parasitic diseases, including avohilmo

10.02

21.47

3.9

1.6

—

Acute upper respiratory infections

4.99

21.33

4.2

2.2

—

Medical observation and evaluation for suspected diseases and conditions

9.20

20.73

3.6

1.5

—

Examination and observation for other reasons

9.31

20.33

4.4

1.5

—

Suppurative and unspecified otitis media

5.54

20.27

5.2

3.8

—

Endocrine, nutritional and metabolic diseases

4.60

20.09

4.5

5.0

—

Anomalies of dental arch relationship, including avohilmo

6.22

20.02

6.5

4.0

—

Persons encountering health services for other counselling and medical advice, not elsewhere classified

4.06

19.92

3.9

4.0

—

Other heart diseases

6.06

19.87

4.7

4.6

—

Disorders of lens

6.20

19.83

3.4

2.1

—

Crowding of teeth, including avohilmo

5.66

19.09

7.4

6.0

—

Disorders of choroid and retina

4.95

18.94

1.7

2.9

—

COPD/asthma related infections

5.78

18.41

4.0

2.0

—

COPD/asthma/ILD related infections

5.78

18.41

4.0

2.0

—

Speech and linguistic disorders, excluding more controls

7.14

18.38

7.1

5.6

—

Diabetic retinopathy

9.87

18.22

1.3

—

Symptoms and signs involving the urinary system

4.35

17.92

4.0

3.8

—

Persons encountering health services in other circumstances, wide

3.81

17.69

4.1

4.0

—

Caries of enamel

3.97

17.67

4.4

2.7

—

Headache

5.97

17.58

4.1

2.0

—

Unspecified haematuria

6.95

17.56

4.4

2.8

—

Certain conditions originating in the perinatal period

5.39

17.21

6.0

5.9

—

Hypoplasia of dental enamel, prenatal , including avohilmo

18.84

17.18

9.8

6.8

—

4.62

16.96

4.1

2.0

—

Polycystic kidney disease

28.06

16.54

2.8

4.9

—

Disorders of refraction and accommodation

4.53

16.42

7.2

5.2

—

Other acute lower respiratory infections

110

3.98

16.25

4.6

4.4

—

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

24.55

15.98

2.3

2.0

—

Disorders of lipoprotein metabolism and other lipidaemias

5.07

15.92

1.4

2.7

—

Other diseases of hard tissues of teeth

10.79

15.85

5.2

1.3

—

Neoplasms

3.62

15.69

4.4

5.0

—

Crossbite

4.85

15.52

6.9

7.1

—

Heart failure and antihypertensive medication

29.91

15.43

3.5

1.0

—

Deep bite

4.74

15.35

7.4

6.5

—

Diabetic retinopathy, strict definition

15.90

15.32

1.2

1.3

—

Infections of the skin and subcutaneous tissue

138

3.57

15.27

4.2

4.5

—

Hypermetropia

7.00

15.23

7.5

7.0

—

Melanocytic naevi

5.88

15.22

4.4

3.9

—

Diseases of middle ear and mastoid

4.18

15.10

4.3

3.3

—

Heart failure,strict

7.98

15.04

3.4

3.7

—

Hypo-osmolality and hyponatraemia

23.20

15.01

3.8

3.4

—

Lack of expected normal physiological development

21.82

14.94

6.1

5.4

—

Hypertension, essential

6.02

14.91

1.4

1.8

—

Type 1 diabetes

4.55

14.86

1.5

5.9

—

Nonsuppurative otitis media

5.43

14.81

5.0

4.7

—

Hydronephrosis

31.77

14.79

3.4

2.0

—

Personal history of other diseases and conditions

31.60

14.75

5.8

1.2

—

Persons with potential health hazards related to communicable diseases

111

3.84

14.65

5.2

5.3

—

Other endocrine disorders

5.40

14.65

7.4

—

Cytomegalovirus infection, IBD co-morbidity

36.69

14.48

3.3

5.0

—

Other disorders starting during childhood or adolecense, excluding more controls

6.70

14.36

8.3

6.1

—

Other metabolic disorders

12.54

14.34

3.5

3.8

—

Insulin, fast-acting (human)

12.54

14.34

1.2

2.9

—

Sub-endpoint used in defining T1D endpoints

4.42

14.30

1.5

5.8

—

Persons encountering health services for examination and investigation

7.27

14.24

3.3

1.5

—

Symptoms and signs concerning food and fluid intake

22.25

14.18

8.2

3.8

—

Zoster [herpes zoster]

14.41

14.02

2.1

3.3

—

Postprocedural endocrine and metabolic disorders, not elsewhere classified

17.56

13.80

1.9

3.0

—

Other disorders of skin and subcutaneous tissue

3.97

13.63

2.8

3.3

—

Diabetic retinopathy, excluding more controls

15.56

13.38

1.3

—

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

3.92

13.16

5.8

5.1

—

Malignant neoplasm

3.41

12.98

3.1

3.9

—

Malignant neoplasm

3.41

12.98

3.1

3.9

—

Vitreous haemorrhage

28.43

12.94

1.2

1.0

—

Other diseases of blood and blood-forming organs, wide

6.12

12.91

5.8

3.9

—

Insulin, fast-acting or short human

4.23

12.85

1.4

5.6

—

Insulin, fast-acting

4.23

12.85

1.4

5.6

—

Other diseases of urinary system

3.27

12.73

4.3

3.7

—

Other bacterial intestinal infections

14.03

12.72

2.6

3.3

—

4.52

12.66

7.7

7.1

—

Diabetic maculopathy

26.82

12.57

1.1

1.2

—

Disorders of psychological development

4.11

12.45

6.1

6.4

—

Diabetic maculopathy, excluding more controls

20.07

12.44

1.1

1.3

—

Bleeding

104

3.30

12.18

2.6

4.3

—

Cough

4.11

12.14

4.8

4.7

—

Malignant neoplasm, wide definition

3.21

12.08

3.1

4.0

—

Any event in cancer register

3.19

11.97

3.1

3.7

—

Disorders of parathyroid gland

26.38

11.95

2.0

—

COPD differential diagnosis

5.36

11.94

3.3

1.9

—

ILD differential diagnosis

5.36

11.94

3.3

1.9

—

Other pulmonary diagnosis

5.36

11.94

3.3

1.9

—

Excluding asthma or asthma-COPD overlap

5.36

11.94

3.3

1.9

—

Malaise and fatigue

5.84

11.78

2.9

2.4

—

Malignant neoplasm, including Hilmo

3.18

11.73

3.1

4.1

—

Hyperparathyroidism

29.71

11.56

2.0

1.2

—

Neurotic, stress-related and somatoform disorders

109

3.16

11.56

4.3

3.1

—

Anxiety disorders

109

3.15

11.48

4.3

3.1

—

Coagulation defects, purpura and other haemorrhagic conditions

5.38

11.33

3.9

5.2

—

Hyperlipidaemia, other/unspecified

11.11

11.27

1.5

1.6

—

Diseases of the eye and adnexa

3.44

11.25

4.2

4.5

—

Nonsuppurative otitis media, including avohilmo

4.33

11.13

4.4

4.1

—

Ulcer of lower limb, not elsewhere classified

25.04

11.12

1.1

2.0

—

Presence of other functional implants

23.29

11.07

2.1

1.8

—

Anxiety disorders, excluding more controls

3.48

10.99

4.4

2.5

—

4.35

10.98

8.2

7.3

—

Other bacterial intestinal infections, including avohilmo

10.02

10.97

2.6

2.8

—

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

15.65

10.84

6.1

7.3

—

Other disorders involving the immune mechanism, not elsewhere classified

15.64

10.84

6.1

7.3

—

Hypertensive heart and/or renal disease

23.39

10.66

4.2

2.4

—

Type 1 diabetes, wide definition

4.03

10.63

1.3

6.0

—

Agranulocytosis

12.90

10.63

5.9

3.6

—

Convulsions, not elsewhere classified

9.44

10.62

5.0

2.9

—

Acute sinusitis

4.64

10.61

4.1

2.1

—

Bacterial intestinal infections, IBD co-morbidities

8.77

10.24

2.6

4.2

—

Mycoses

4.70

10.22

3.7

3.8

—

Congenital obstructive defects of renal pelvis and congenital malformations of ureter

13.33

10.19

7.3

6.6

—

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

4.28

10.18

8.3

6.3

—

Heart failure, strict

5.05

10.15

3.4

2.8

—

All influenza (not pneumonia)

7.88

10.07

6.4

4.9

—

Oedema, not elsewhere classified

9.31

10.06

3.3

1.5

—

Polyneuropathies and other disorders of the peripheral nervous system

9.11

9.99

2.5

3.3

—

All-cause Heart Failure

5.16

9.94

3.5

2.9

—

Other and unspecified tonsillitis

4.64

9.90

5.3

2.7

—

Short stature, not elsewhere classified

4.54

9.84

7.2

7.4

—

Diseases of arteries, arterioles and capillaries (FINNGEN)

14.67

9.67

1.1

1.9

—

Acute bronchiolitis

3.92

9.57

6.1

6.5

—

Acute bronchitis

3.63

9.52

4.0

4.8

—

Type 1 diabetes, wide definition, subgroup 1

3.86

9.36

1.1

5.9

—

Symptoms and signs involving the digestive system and abdomen

2.79

9.25

5.0

4.1

—

Speech and linguistic disorders

3.57

9.18

7.2

6.4

—

Other heart diseases, wide

130

2.61

9.02

4.5

4.2

—

Hyperkinetic disorders, excluding more controls

5.07

9.00

6.0

5.3

—

Erysipelas

4.93

8.94

1.4

—

Other diseases of arteries and capillaries

24.05

8.90

1.1

1.8

—

Osteopathies and chondropathies

3.41

8.83

3.0

4.0

—

Erysipelas, including avohilmo

4.34

8.81

1.6

1.3

—

Gout, FINNGEN

10.60

8.73

1.8

1.3

—

Irregular menses

4.43

8.70

2.3

1.9

—

Diseases of arteries, arterioles and capillaries

3.88

8.62

1.0

2.0

—

Other and unspecified polyneuropathies, also in other diseases

11.56

8.55

1.7

2.4

—

Insulin, combination of fast acting with intermediate-acting or long-acting

3.15

8.52

1.4

4.7

—

Tooth eruption problems

3.52

8.46

5.3

5.6

—

Non-Hodgkin lymphoma, all, including Hilmo

12.75

8.36

2.6

3.7

—

Symptoms and signs involving the skin and subcutaneous tissue

124

2.89

8.35

3.3

4.1

—

Bacterial pneumoniae

4.39

8.29

3.8

3.7

—

Peripheral artery disease

8.36

8.26

1.1

1.2

—

Tramadol

3.96

8.24

1.6

1.4

—

Otitis externa

4.08

8.24

6.8

4.5

—

Disorders of vitreous body

4.63

8.20

1.2

1.4

—

Enterocolitis due to Clostridium difficile

14.47

8.19

2.6

2.9

—

Peripheral artery operations in Hilmo

22.02

8.00

1.1

1.6

—

Disorders of vitreous body and globe

4.49

7.90

1.2

1.6

—

Other medical care

6.93

7.89

3.5

3.7

—

Stomatitis and related lesions

4.42

7.88

5.9

3.8

—

Need for other prophylactic measures

10.82

7.79

7.6

6.8

—

Cellulitis

4.04

7.78

4.3

4.9

—

Diseases of the respiratory system

4.46

7.78

3.8

2.0

—

Disorders of sclera, cornea, iris and ciliary body

3.30

7.76

2.4

3.1

—

Senile cataract

4.86

7.73

1.2

1.4

—

Glaucoma

4.48

7.62

1.4

1.7

—

Viral pneumonia

8.02

7.58

3.3

4.3

—

Disease of hard tissues of teeth, NOS

8.57

7.55

3.1

1.4

—

Varicella [chickenpox]

10.06

7.53

4.5

5.3

—

Recurrent aphthous stomatitis , including avohilmo

6.14

7.52

5.9

4.5

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

5.16

7.49

1.9

3.3

—

Congenital vesicoureteral reflux

13.94

7.46

7.9

6.6

—

Bacterial pneumonia, not elsewhere classified

4.18

7.46

3.6

3.7

—

Statin medication

3.36

7.45

2.3

2.7

—

Oxycodone

6.25

7.41

1.5

1.3

—

Gout

8.08

7.40

1.8

1.2

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

7.68

7.39

7.1

6.9

—

Type 2 diabetes, wide definition

3.32

7.38

1.2

1.4

—

Diseases of external ear

3.43

7.37

6.6

4.5

—

Cutaneous abscess, furuncle and carbuncle

4.00

7.33

3.1

4.2

—

Retinal haemorrhage

+∞

7.30

2.0

0.0

—

Acute pharyngitis

5.89

7.29

6.5

3.3

—

Other postsurgical states

+∞

7.29

6.4

0.0

—

Insulin, intermediate and long-acting

3.05

7.28

1.2

4.7

—

Insulin medication

2.85

7.10

1.4

4.6

—

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

8.53

7.06

3.9

1.2

—

Keratitis

3.75

7.06

2.7

3.5

—

Diabetic neuropathy

11.97

7.05

1.1

1.2

—

Volume depletion

10.02

7.02

4.5

4.7

—

Hernia

115

2.54

7.02

5.5

3.5

—

Autoimmune diseases excluding thyroid diseases, strict definition

125

2.35

6.94

2.9

4.7

—

Other strabismus

3.37

6.90

6.0

5.3

—

Other congenital malformations of the digestive system

3.85

6.90

6.5

7.4

—

Opioids

3.10

6.86

1.9

2.0

—

Other disorders starting during childhood or adolescence

3.37

6.84

8.9

6.6

—

Rare circulating lymphoid malignancy, including Hilmo

8.32

6.83

4.5

6.8

—

9.30

6.77

2.5

1.7

—

Persons encountering health services in other circumstances

3.65

6.77

4.6

—

Autoimmune diseases excluding thyroid diseases

126

2.32

6.77

2.9

4.7

—

Immunodeficiency with predominantly antibody defects

16.81

6.75

4.7

6.3

—

Dermatitis

112

2.79

6.72

4.6

3.5

—

Specific development disorders of scholastic skills

3.90

6.67

6.8

7.0

—

Melanocytic naevi of trunk

7.79

6.60

4.5

3.8

—

Venous thromboembolism

4.20

6.56

1.8

1.6

—

Distal bite

3.71

6.56

9.2

6.7

—

Diseases of pulp and periapical tissues and dental caries

3.66

6.56

4.4

4.0

—

Invasive ventilation

10.03

6.53

7.4

5.3

—

Any death

3.36

6.51

1.6

2.3

—

All anxiety disorders

2.82

6.49

3.7

3.2

—

Nutritional anaemias

3.44

6.47

5.2

3.8

—

Strabismus

3.00

6.44

5.6

—

Childhood asthma (age<16)

9.24

6.42

3.7

3.4

—

Other and unspecified dermatitis

2.97

6.36

5.0

3.5

—

Medullary cystic kidney disease, nephronophthisis

+∞

6.35

3.8

0.0

—

Cystitis

2.77

6.20

3.9

4.1

—

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

3.99

6.18

7.2

—

Overjet

3.68

6.16

8.8

6.9

—

Varicella [chickenpox], including avohilmo

6.28

6.15

4.3

6.2

—

Excessive, frequent and irregular menstruation

4.78

6.12

3.1

2.1

—

Lymphoid leukaemia

7.68

6.12

4.8

6.4

—

Dental caries, including avohilmo

3.19

6.08

4.0

3.6

—

7.79

6.06

1.2

1.7

—

Immunodeficiencies

8.62

6.05

4.1

4.9

—

Pain, not elsewhere classified

6.67

6.02

2.2

2.7

—

Bacterial pneumonia (organism specified)

3.20

6.01

3.7

4.0

—

Urinary track infection

3.80

6.00

4.0

3.1

—

Dentofacial anomalies [including malocclusion]

2.69

5.99

5.3

2.2

—

Other anxiety disorders

3.14

5.98

2.4

3.3

—

Otitis externa, unspecified

5.53

5.98

6.6

4.6

—

Non-ischemic cardiomyopathy

5.77

5.93

4.6

3.2

—

Diseases of the skin and subcutaneous tissue

2.51

5.92

4.0

3.9

—

Follow-up examination after treatment for conditions other than malignant neoplasms

6.66

5.92

2.5

1.3

—

Abnormal findings on examination of urine, without diagnosis

15.06

5.90

1.9

6.2

—

Polycystic ovarian syndrome, consortium definition

3.36

5.87

2.3

1.8

—

Abnormalities of breathing

103

2.39

5.86

3.4

3.7

—

Candidiasis

6.37

5.85

3.8

4.4

—

Herpesviral [herpes simplex] infections, including avohilmo

5.34

5.83

4.1

2.4

—

Non-follicular lymphoma

11.14

5.79

3.1

2.8

—

Other congenital malformations of the digestive system, including avohilmo

3.39

5.78

6.5

7.5

—

Childhood asthma (age<16), excluding more controls

8.53

5.74

3.3

3.4

—

Other disorders of bone

5.17

5.69

3.6

3.1

—

Iron deficiency anaemia

3.33

5.65

5.5

3.8

—

Actinic keratosis

7.80

5.64

1.0

1.1

—

Open bite

3.71

5.64

6.4

6.9

—

Skin changes due to chronic exposure to nonionizing radiation

7.76

5.62

1.0

1.1

—

Other noninfective gastroenteritis and colitis

3.03

5.62

4.7

5.5

—

Acute laryngitis and tracheitis

6.00

5.60

6.1

4.1

—

Peripheral arterial reconstruction

12.87

5.57

1.1

1.0

—

Other diseases of lip and oral mucosa

3.28

5.57

4.7

3.1

—

Asthma (only as main-diagnosis), excluding more controls

3.89

5.56

3.1

2.0

—

Atherosclerosis, excluding cerebral and coronary sclerosis

6.81

5.46

1.1

1.3

—

Diseases of oral cavity, salivary glands and jaws

6.44

5.45

3.7

1.3

—

Rash and other nonspecific skin eruption

7.07

5.43

4.8

6.1

—

Asthma (only as main-diagnosis)

3.79

5.42

3.1

1.9

—

Multiple myeloma and malignant plasma cell neoplasms

16.06

5.41

1.1

2.2

—

Diseases of oesophagus, stomach and duodenum

115

2.26

5.39

1.8

3.9

—

Candidiasis, including avohilmo

3.72

5.36

3.6

3.8

—

Neurological diseases, wide definition

3.72

5.34

4.4

5.2

—

Viral pneumonia (unknown virus, not influenza)

7.88

5.34

3.7

5.1

—

Asthma

3.68

5.33

2.9

1.9

—

Drug-induced polyneuropathy

11.53

5.32

3.7

6.4

—

Hypothyroidism (congenital or acquired)

10.26

5.31

3.5

5.2

—

Disorders of gallbladder, biliary tract and pancreas

2.43

5.26

3.5

2.3

—

Exclusions for E4_PCOS_BROAD

2.98

5.23

6.9

5.8

—

Emotional disorders starting during childhood or adolecense, excluding more controls

5.45

5.22

5.7

6.2

—

Artificial opening status

+∞

5.21

4.4

0.0

—

Cerebrovascular diseases (FINNGEN)

6.51

5.19

2.5

1.3

—

Intermittent heterotropia

4.58

5.16

6.3

7.3

—

Coronary atherosclerosis

3.66

5.14

1.1

1.2

—

Tonsillectomy and adenotomy

128

2.23

5.10

6.2

4.5

—

Special screening examination for other diseases and disorders

13.34

5.07

2.5

1.7

—

Used for control exclusion in common control thyroid runs

123

2.09

5.02

4.3

4.7

—

Disturbance of activity and attention

2.98

4.98

6.4

5.5

—

Asthma, excluding more controls

3.61

4.94

2.6

2.0

—

Covid-19 suspected case

3.66

4.91

5.6

3.4

—

In situ neoplasms

5.42

4.90

1.5

1.1

—

Complications of procedures, not elsewhere classified

2.62

4.89

2.6

2.9

—

Herpesviral [herpes simplex] infections

7.70

4.84

5.5

1.9

—

Use of pramipexole

7.70

4.84

1.7

2.3

—

Pure hypercholesterolaemia

3.04

4.83

1.3

2.7

—

Disorders of skin appendages

100

2.59

4.82

4.5

3.5

—

Other embolism and thrombosis

11.44

4.78

2.0

1.4

—

Gout, unspecified

9.01

4.78

2.3

1.3

—

Codeine

2.95

4.77

1.6

1.3

—

Speech therapy

4.42

4.73

4.1

3.5

—

Asthma (mode)

3.44

4.69

2.4

1.9

—

Hypothyroidism, levothyroxine purchases

9.34

4.68

3.4

5.2

—

Hypothyroidism and >3 levothyroxin purchases

9.34

4.68

3.4

5.2

—

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

2.93

4.67

3.0

2.9

—

Bacterial, viral and other infectious agents

7.16

4.65

6.9

4.1

—

Gout, idiopatic and unspecified

7.15

4.64

2.2

1.2

—

Glaucoma suspect

5.00

4.62

1.5

1.3

—

STROKE

3.20

4.60

1.7

2.7

—

Other diseases of pericardium

14.04

4.57

4.0

5.6

—

Other necrotizing vasculopathies

14.03

4.57

4.1

3.0

—

Inflammatory diseases of female pelvic organs

3.17

4.57

1.7

1.8

—

Enlarged lymph nodes

8.19

4.55

4.9

2.8

—

Undetermined asthma

8.18

4.55

4.4

3.3

—

Undetermined asthma, excluding more controls

8.18

4.55

4.4

3.3

—

Pain (limb, back, neck, head abdominally)

2.27

4.54

4.4

4.8

—

Visual disturbances and blindness

2.55

4.52

4.2

4.6

—

Symptoms and signs involving the circulatory and respiratory systems

104

2.12

4.51

4.4

3.7

—

Pain in limb

123

2.12

4.47

4.0

4.2

—

Anxiety (asthma-related co-morbidities)

101

2.33

4.41

3.7

3.6

—

Depression medications

8.38

4.32

3.6

5.7

—

Other infectious diseases, including avohilmo

8.90

4.28

2.4

4.9

—

Explicit bacterial Sepsis

8.90

4.27

6.3

6.6

—

Explicit bacterial Sepsis, including avohilmo

8.90

4.27

6.2

6.6

—

Neuromuscular dysfunction of bladder

11.68

4.27

2.0

2.2

—

Respiratory and cardiovascular disorders specific to the perinatal period

2.70

4.26

7.3

7.5

—

Non-allergic asthma (mode)

6.20

4.25

5.4

2.6

—

Any mental disorder

2.17

4.24

4.5

3.0

—

Abdominal and pelvic pain

2.12

4.24

5.6

4.1

—

Polyuria

5.89

4.12

1.7

1.9

—

Purpura and other haemorrhagic conditions

4.34

4.12

4.7

5.8

—

Delayed milestone in childhood

2.77

4.07

6.5

8.2

—

Inguinal hernia

2.39

4.06

6.5

3.5

—

Other and unspecified drugs and medicaments

8.01

4.06

3.3

2.3

—

Other infectious diseases

10.02

4.01

2.6

4.1

—

Other disorders of bladder

10.01

4.01

1.0

2.0

—

Noninflammatory disorders of female genital tract

3.49

3.98

3.9

3.3

—

Non-allergic asthma (mode), excluding more controls

5.51

3.94

5.4

2.4

—

Asthma, unspecified (mode)

4.04

3.92

4.6

2.0

—

Heart failure and coronary heart disease

4.34

3.89

2.5

3.3

—

Asthma, unspecified (mode), excluding more controls

4.01

3.89

4.6

2.0

—

Systemic connective tissue disorders

3.79

3.88

2.9

3.0

—

Thrombocytopenia, unspecified

7.29

3.86

6.4

6.5

—

Chronic pancreatitis

7.28

3.85

2.0

1.9

—

Hernia of abdominal wall

2.77

3.84

5.7

2.4

—

Interstitial emphysema and related conditions originating in the perinatal period

13.14

3.84

10.3

2.8

—

Bacterial, viral and other infectious agents, including avohilmo

5.27

3.82

6.9

4.8

—

Amblyopia ex anopsia

3.96

3.79

5.7

7.3

—

Astigmatism

3.95

3.78

8.5

6.8

—

Other benign neoplasms of skin

3.18

3.77

2.1

2.6

—

Secondary and unspecified malignant neoplasm of lymph nodes

12.02

3.76

4.0

6.2

—

Infections with a predominantly sexual mode of transmission

3.18

3.75

1.7

1.9

—

Contraceptive management

2.86

3.73

2.6

1.5

—

Fitting and adjustment of other devices

5.18

3.70

3.7

2.9

—

Congenital malformations and deformations of the musculoskeletal system

2.63

3.68

6.5

7.0

—

Other CVD

6.67

3.67

3.0

—

Acute pancreatitis (for exclusion)

5.63

3.65

3.8

2.8

—

Diseases of the musculoskeletal system and connective tissue

2.05

3.65

4.8

5.4

—

Continuous positive airway pressure

3.87

3.63

7.5

6.1

—

Diseases of the ear and mastoid process

104

1.98

3.58

4.0

2.6

—

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

2.52

3.58

6.7

—

Cardiac murmurs and other cardiac sounds

3.08

3.57

8.1

6.6

—

Procreative management

100

2.22

3.56

5.1

5.8

—

Haemolytic anaemias

7.81

3.56

7.4

6.0

—

Melanocytic naevi, other sites/unspecified

7.79

3.56

3.4

3.9

—

Streptococcal septicaemia

7.79

3.55

6.9

5.2

—

Streptococcal septicaemia, including avohilmo

7.79

3.55

6.9

5.2

—

Coxibs

0.00

3.52

0.0

2.4

—

Congenital malformations of gallbladder, bile ducts and liver

10.14

3.51

4.2

6.8

—

Pruritus

5.30

3.50

2.1

3.8

—

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

6.16

3.50

3.3

3.1

—

Benign neoplasm: Skin of other and unspecified parts of face

10.01

3.49

1.0

—

COPD-related respiratory insufficiency

10.01

3.49

1.0

—

Hypotension

10.00

3.49

2.2

1.0

—

Embedded and impacted teeth

2.41

3.47

5.0

4.6

—

Autoimmune diseases

129

1.85

3.43

3.6

4.7

—

Psychiatric diseases

2.06

3.43

4.9

3.1

—

Motor disorders, excluding more controls

4.18

3.41

6.5

7.0

—

Hypopituitarism

3.52

3.39

7.5

6.7

—

Other disorders of adrenal gland

7.02

3.36

8.3

5.6

—

Other coagulation defects

7.01

3.36

2.6

3.7

—

Misadventures to patients during surgical and medical care

7.00

3.36

2.3

1.0

—

Hyperkinetic disorders

2.34

3.36

6.5

6.3

—

Gingivitis and periodontal diseases

1.99

3.35

4.5

4.6

—

Unspecified privation

5.72

3.34

2.8

4.4

—

Umbilical hernia

3.42

3.30

5.8

2.1

—

6-mercaptopurine

8.60

3.26

3.3

6.6

—

Other and unspecified coagulation defects

8.59

3.26

2.2

4.1

—

Other otitis externa (chronic)

8.59

3.26

5.2

3.6

—

Cardiomyopathy, other and unspecified

8.58

3.26

3.3

6.6

—

Secondary uncertain malignant neoplasm

8.58

3.26

4.0

4.9

—

Mandibular retrognathia

3.33

3.21

9.9

6.0

—

Asthma-related pneumonia

2.37

3.19

4.8

5.4

—

Chronic gastritis

5.34

3.19

1.0

1.6

—

Seborrhoeic keratosis

6.37

3.18

1.9

1.7

—

Gastroduodenal ulcer

6.35

3.17

1.7

1.9

—

Emotional disorders and disorders of social functioning with onset specific to childhood

2.86

3.17

5.7

6.5

—

Retention of urine

4.26

3.14

1.1

2.7

—

Parasetamol

2.11

3.13

2.7

3.9

—

Asthma-related pneumonia or sepsis

2.35

3.12

4.8

5.4

—

Asthma, hospital admissions 3, pneumonia

2.35

3.12

4.9

5.4

—

Injury of muscle and tendon at wrist and hand level

4.50

3.11

1.1

2.5

—

Noninfective enteritis and colitis

111

2.16

3.10

4.5

4.9

—

Male infertility

7.52

3.05

2.5

1.8

—

Atrial fibrillation and flutter

4.84

3.05

1.2

1.3

—

Iron deficiency anaemia secondary to blood loss (chronic)

5.00

3.05

3.1

2.7

—

Nonischemic cardiomyopathy

5.00

3.04

1.5

5.1

—

Tooth agenesis EXCLUDE clefts and syndromes

3.34

3.01

5.4

7.0

—

Disorders in reading

4.33

3.00

7.2

7.3

—

Acute pancreatitis

4.29

2.99

3.8

2.5

—

Malignant neoplasm of urinary organs

10.01

2.98

2.6

5.8

—

Hypothyroidism, strict autoimmune

2.44

2.95

2.1

3.5

—

Noninfectious colitis NAS

3.25

2.93

2.1

4.7

—

Dental operations

3.18

2.91

3.4

1.4

—

Polyarthropathies

2.04

2.90

2.7

3.8

—

Sequelae with surgical and medical care as external cause

4.09

2.88

2.9

3.0

—

Phlebitis and thrombophlebitis (not including DVT)

4.09

2.88

1.2

2.0

—

Cardiomyopathy

4.09

2.87

3.0

4.8

—

Chondropathies

3.71

2.87

4.6

3.3

—

Cholangitis (primary sclerosing, PSC)

6.68

2.87

5.7

5.1

—

Hypokalaemia

6.67

2.86

5.5

4.0

—

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

6.67

2.86

4.0

4.3

—

Gout, strict definition

6.67

2.86

1.3

—

Sequelae of external causes of morbidity and mortality

3.16

2.84

2.4

3.3

—

128

2.02

2.84

4.5

5.1

—

Specific development disorders of speech and language

2.49

2.82

7.9

7.0

—

Embedded teeth, including avohilmo

3.34

2.80

3.5

5.1

—

Corneal ulcer

3.34

2.80

2.0

3.5

—

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

4.49

2.80

4.6

6.6

—

Abscess of anal and rectal regions

4.45

2.79

1.3

4.8

—

Mental retardation, excluding more controls

3.59

2.77

5.7

7.1

—

Other predominantly sexually transmitted diseases, not elsewhere classified

3.92

2.77

1.8

1.9

—

Unspecified acute lower respiratory infection

3.08

2.76

4.1

3.7

—

Other congenital malformations of upper alimentary tract

8.46

2.76

9.0

5.7

—

Amenorrhoea

8.34

2.75

1.4

2.7

—

Migraine, single triptan purchase ok & required. ICD-code if available is included

129

0.31

2.74

4.2

3.2

—

Triptan medication for migraine, single purchase ok

129

0.31

2.74

4.2

3.2

—

Acute lymphocytic leukaemia, helper endpoint

5.10

2.74

5.3

7.0

—

Acute lymphocytic leukaemia

5.10

2.74

5.3

7.0

—

Acute lymphocytic leukaemia, including Hilmo

5.10

2.74

5.3

7.0

—

Other soft tissue disorders, not elsewhere classified

128

1.78

2.73

4.1

4.3

—

Nontraumatic intracranial haemmorrhage

5.00

2.72

2.6

1.9

—

Solid cancers

2.03

2.71

3.1

3.3

—

Osteoporosis

4.32

2.70

2.9

4.5

—

Missing teeth due to accident, extraction or parodontitis

2.37

2.68

2.0

—

Other and unspecified local infections of skin and subcutaneous tissue

4.22

2.67

4.4

5.1

—

Other local infections of skin and subcutaneous tissue

4.22

2.67

4.4

5.1

—

Solid cancers, including Hilmo

1.99

2.67

3.1

3.5

—

Other skin changes

3.75

2.67

2.2

3.5

—

Diaphragmatic hernia

3.75

2.67

1.3

1.8

—

Visual disturbances

2.17

2.66

4.7

4.5

—

Autoimmune diseases related-to ILD

134

1.87

2.60

2.9

3.2

—

Trigger finger

4.67

2.59

1.0

2.1

—

Phobic anxiety disorders

3.33

2.59

5.0

4.3

—

Other neurological diseases

2.11

2.59

2.3

2.8

—

Congenital malformations of the circulatory system

2.11

2.57

5.1

6.8

—

Other disorders of glucose regulation and pancreatic internal secretion

3.61

2.57

2.1

6.6

—

Malnutrition

4.03

2.57

5.4

7.1

—

Other diseases of intestines

153

1.67

2.57

3.4

4.6

—

Conjunctivitis (acute, non atopic)

100

2.09

2.55

4.8

5.6

—

Other osteochondropathies

7.15

2.55

6.4

3.1

—

Persons encountering health services for specific procedures, not carried out

7.15

2.55

1.4

2.6

—

Other respiratory diseases principally affecting the interstitium

5.46

2.54

1.2

2.5

—

Congenital malformations of heart and great arteries

2.14

2.54

4.7

7.3

—

Disturbances of skin sensation

3.23

2.51

2.1

2.3

—

Fracture of rib(s), sternum and thoracic spine

3.23

2.51

1.1

2.3

—

Codeine or tramadol medication

1.95

2.50

1.5

1.3

—

Pain and other conditions associated with female genital organs and menstrual cycle

3.93

2.46

2.5

1.5

—

Nerve, nerve root and plexus disorders

1.91

2.43

1.5

2.4

—

Chronic diseases of tonsils and adenoids

139

1.72

2.43

6.0

3.9

—

Benign neoplasms

115

1.75

2.41

3.9

3.5

—

Sleep disorders (combined)

142

0.40

2.40

2.8

3.4

—

Other complications of surgical and medical care, not elsewhere classified

5.01

2.40

2.7

2.3

—

Seborrhoeic dermatitis

5.00

2.40

4.5

5.3

—

Disorders of synovium and tendon

2.25

2.40

3.1

2.5

—

Degeneration of macula and posterior pole

3.47

2.40

2.2

—

Gastro-oesophageal reflux disease

2.02

2.38

2.0

4.0

—

Hyperfunction of pituitary gland

6.26

2.37

3.2

4.9

—

Malignant neoplasm of urinary organs, including Hilmo

6.25

2.37

2.6

5.9

—

Bronchitis, not specified as acute or chronic

6.26

2.37

1.6

1.4

—

Intracerebral haemorrhage

6.25

2.37

3.2

2.6

—

Other and unspecified iron deficiency

2.50

2.34

6.5

4.1

—

Atrial fibrillation and flutter with reimbursement

5.40

2.32

1.0

1.6

—

Chronic periodontitis, including avohilmo

1.91

2.29

1.5

1.8

—

Periodontitis

1.90

2.28

1.5

1.8

—

Non-invasive ventilation

3.24

2.27

5.4

4.8

—

Intestinal stricture

2.94

2.27

2.3

3.2

—

Budesonide

4.62

2.27

1.2

1.5

—

Other disorders of skin and subcutaneous tissue, not elsewhere classified

4.62

2.27

1.3

4.7

—

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

2.01

2.27

2.2

3.5

—

Impacted cerumen

3.48

2.27

7.0

4.8

—

Orchitis and epididymitis

3.89

2.25

3.3

3.8

—

Oral corticosteroids

1.90

2.24

2.3

2.1

—

Soft tissue disorders

134

1.64

2.24

4.8

4.4

—

Chronic periodontitis, complicated

2.35

2.23

1.9

1.3

—

Mouth breathing

120

1.91

2.23

5.9

5.1

—

Juvenile osteochondrosis

5.57

2.21

5.0

4.9

—

Other epidermal thickening

5.57

2.21

2.4

5.7

—

Cysts of oral region, not elsewhere classified

5.56

2.21

2.4

4.3

—

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

2.86

2.20

1.9

2.4

—

Asthma, hospital admission 2, infections

146

1.80

2.19

4.4

4.6

—

Asthma-related infections

146

1.80

2.19

4.4

4.6

—

Emotional disorders starting during childhood or adolescence

2.32

2.17

5.7

7.1

—

Special screening examination for infectious and parasitic diseases

3.93

2.16

1.6

1.2

—

Disorders of puberty, all

3.03

2.15

4.7

6.8

—

Perforation of tympanic membrane

4.29

2.15

6.7

5.2

—

Conductive hearing loss, unspecified

3.69

2.15

6.4

5.2

—

Myocardial infarction

2.91

2.15

1.1

1.7

—

Impetigo

3.01

2.14

5.2

7.0

—

Contact with and exposure to communicable diseases

101

1.97

2.12

4.6

5.4

—

Infections with a predominantly sexual mode of transmission, including avohilmo

2.15

2.08

1.8

2.3

—

Type 2 diabetes

1.93

2.07

1.3

2.0

—

Other female pelvic inflammatory diseases

5.00

2.07

1.6

—

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

3.04

2.06

1.8

1.7

—

Finngen Rheumatological endpoints

114

1.69

2.04

3.2

3.6

—

Dermatophytosis

4.00

2.04

3.2

2.6

—

Other diseases of intestine

4.00

2.04

2.2

2.6

—

Hard cardiovascular diseases

115

1.69

2.01

2.7

4.7

—

Other systemic involvement of connective tissue (FG)

3.44

2.01

1.7

2.4

—

Symptoms and signs involving the nervous and musculoskeletal systems

125

1.84

2.01

3.5

4.9

—

Other systemic involvement of connective tissue

3.08

2.01

1.8

2.3

—

Other diseases of pleura

2.42

2.01

1.9

3.5

—

Hyperplasia of prostate

2.82

2.00

1.0

—

DVT of lower extremities and pulmonary embolism

2.80

1.98

2.3

1.2

—

Sleep disorders

133

0.41

1.97

2.0

2.9

—

Localized swelling, mass and lump of skin and subcutaneous tissue

2.28

1.97

3.7

4.6

—

Haemorrhage from respiratory passages

2.30

1.96

3.0

4.1

—

Major coronary heart disease event excluding revascularizations

2.47

1.96

1.2

1.5

—

Congenital stenosis of pulmonary valve

4.61

1.95

7.0

6.9

—

Adjustment and management of implanted device

4.55

1.94

1.0

3.5

—

Acute lymphadenitis

3.76

1.93

5.2

5.7

—

Rosacea

3.75

1.93

5.3

2.6

—

Ischaemic heart disease, wide definition

2.09

1.92

1.1

1.3

—

Diseases of the digestive system

2.01

1.91

2.8

4.2

—

Exposure to unspecified factor

173

1.57

1.90

3.1

4.4

—

Injuries to the thorax

2.15

1.87

1.5

2.8

—

Basal cell carcinoma, including Hilmo

3.01

1.86

1.1

1.8

—

Congenital deformities of feet, including avohilmo

3.54

1.84

5.5

5.6

—

Convergent concomitant strabismus

3.54

1.83

4.3

6.4

—

Pain associated with micturition

3.53

1.83

4.8

5.8

—

Pulmonary embolism

3.53

1.83

3.0

1.2

—

Pulmonary heart disease

3.53

1.83

3.0

1.2

—

Acne

2.38

1.83

6.0

4.4

—

Major coronary heart disease event

111

1.67

1.82

2.5

4.5

—

Cerebral cysts

4.17

1.82

2.6

4.9

—

Atrophic disorders of skin

4.17

1.82

5.6

4.3

—

Pre-eclampsia

4.17

1.82

1.0

1.6

—

Pre-eclampsia or eclampsia

4.17

1.82

1.0

1.6

—

Early onset COPD, excluding more controls

4.16

1.82

1.0

—

Isolated growth hormone deficiency

2.81

1.80

6.9

8.0

—

Abnormal findings on diagnostic imaging of lung

2.37

1.79

1.5

2.1

—

Urticaria

1.95

1.79

7.5

4.9

—

Percutaneous Coronary Intervention

109

1.67

1.79

2.5

4.6

—

Coronary revascularization (ANGIO or CABG)

109

1.67

1.78

2.5

4.6

—

Non-rheumatic valve diseases

2.10

1.78

5.7

4.4

—

Heart failure and bmi 25plus

3.64

1.77

1.0

1.3

—

Scissor bite

2.25

1.77

8.4

6.9

—

Syncope and collapse

2.78

1.77

1.0

1.8

—

Disorders of puberty

3.35

1.75

4.7

6.8

—

Other gastritis (incl. Duodenitis)

3.33

1.74

1.0

2.3

—

Respiratory distress of newborn

2.18

1.74

6.2

7.7

—

Insomnia

128

0.43

1.72

2.0

2.6

—

Diabetes, insuline treatment (Kela reimbursement), excluding more controls

112

1.64

1.72

1.5

4.3

—

Mild mental retardation

2.93

1.72

5.6

6.0

—

Functional dyspepsia

2.67

1.72

1.0

2.4

—

Congenital deformities of feet

3.86

1.71

4.8

5.9

—

Personality disorders, excluding more controls

2.66

1.71

2.0

1.4

—

Other keratitis

3.85

1.71

3.8

3.4

—

Dermatitis and eczema

154

1.54

1.71

3.6

3.8

—

Unstable angina pectoris

3.37

1.70

1.2

1.4

—

Other arthritis (FG)

2.29

1.70

3.8

—

Malignant neoplasm of skin, including Hilmo

2.58

1.68

1.7

1.6

—

COPD (mode)

3.90

1.67

1.0

—

Other disorders of optic [2nd] nerve and visual pathways

3.16

1.66

3.8

6.1

—

Nail disorders

3.16

1.66

3.2

4.9

—

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

1.72

1.66

2.0

2.4

—

Other disorders of eyelid

2.48

1.65

1.4

2.8

—

Other specified congenital malformation syndromes affecting multiple systems

2.82

1.65

3.4

8.4

—

Disorders of optic nerve and visual pathways

2.80

1.65

3.6

5.2

—

Cerebral palsy and other paralytic syndromes

2.80

1.65

4.0

4.8

—

Other disorders of lacrimal gland

2.25

1.63

3.1

2.7

—

Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium

2.41

1.62

1.0

1.5

—

Visual impairment including blindness (binocular or monocular)

3.58

1.61

2.4

5.5

—

Ocular pain

3.57

1.61

4.6

5.3

—

Specific developmental disorder of motor function

2.25

1.61

6.5

7.8

—

Caries of dentine, including avohilmo

1.66

1.60

3.5

5.2

—

Emergency coronary revascularization (for ACS)

112

1.62

1.60

2.5

4.5

—

Anterior Iridocyclitis

2.50

1.59

1.5

2.8

—

Stroke, including SAH

2.05

1.59

1.8

1.6

—

Myocardial infarction, strict

2.57

1.58

1.1

1.4

—

Conjunctivitis (acute, non atopic), including avohilmo

146

1.53

1.58

4.4

3.7

—

Open wound of lower leg

2.27

1.55

1.8

4.5

—

Polyp of the female genital tract

2.83

1.54

1.4

1.7

—

Eustachian salpingitis and obstruction

3.34

1.52

5.0

3.3

—

Urticaria and erythema

100

1.80

1.52

7.2

4.8

—

Cerebrovascular diseases

1.87

1.51

2.2

2.3

—

Other respiratory disorders and diseases

2.59

1.51

2.0

4.7

—

Other diseases of the respiratory system

2.59

1.51

2.0

4.7

—

Retinal detachments and breaks

2.86

1.50

2.0

1.8

—

Impacted teeth

1.92

1.50

6.4

4.6

—

Mycoses, including avohilmo

152

1.55

1.48

3.5

3.6

—

Other degenerative diseases of the nervous system

2.92

1.47

1.5

1.0

—

Diabetes, insulin treatment (Kela reimbursement)

118

1.56

1.46

1.5

4.1

—

Other specified/unspecified arthritis

2.22

1.46

3.7

3.9

—

Acute and subacute iridocyclitis

2.50

1.45

1.6

2.6

—

Exclusion endpoint for clefts

2.51

1.45

3.4

7.6

—

Pregnancy hypertension

2.37

1.45

1.0

1.5

—

Fibroblastic disorders

3.13

1.44

1.0

1.2

—

Obsessive-compulsive disorder

3.13

1.43

5.0

4.8

—

Hypoglycaemia, other or unspecified

2.73

1.43

1.5

7.1

—

Pulmonary heart disease, diseases of pulmonary circulation

2.73

1.43

3.0

2.5

—

Other disorders of eye and adnexa

2.31

1.42

4.3

4.2

—

Other/unspecified dorsalgia

2.09

1.40

3.0

2.8

—

Persons encountering health services in circumstances related to reproduction

130

1.55

1.40

5.0

—

Superficial injury of ankle and foot

2.18

1.39

5.7

5.3

—

Fracture of skull and facial bones

2.17

1.39

6.0

3.6

—

Oter anti-inflammatory and antirheumatic agents, non-steroids

0.00

1.39

0.0

1.1

—

Calcific aortic valvular stenosis, diagnosis (helper)

3.01

1.38

1.4

2.1

—

Operations 2 for CAVS

3.01

1.38

1.4

2.1

—

Calcific aortic valvular stenosis, including rheumatic fever

3.00

1.38

1.4

2.1

—

Cardiovascular disorders originating in the perinatal period

3.00

1.36

6.8

6.0

—

Heterophoria

2.61

1.36

5.5

7.0

—

Soft tissue disorders related to use, overuse and pressure

2.61

1.36

2.2

1.5

—

Congenital malformations of pulmonary and tricuspid valves

2.97

1.36

7.0

8.2

—

Slow fetal growth and fetal malnutrition

2.63

1.36

4.0

6.8

—

Other diseases of anus and rectum

2.19

1.36

3.8

3.3

—

Ventral hernia

2.94

1.36

6.4

1.7

—

Allergic rhinitis

123

0.40

1.35

2.4

5.8

—

Paroxysmal tachycardia

2.97

1.34

3.2

5.4

—

Uterine polyps

2.70

1.32

1.5

1.2

—

Sequelae of cerebrovascular disease

2.56

1.31

1.0

1.2

—

Diagnoses used for exclusion with ILD

2.50

1.30

4.0

2.0

—

Other intervertebral disc disorders

0.41

1.29

1.4

—

Diabetes mellitus

119

1.50

1.26

1.6

4.4

—

Valvular heart disease excluding rheumatic fever

1.81

1.26

5.7

4.8

—

Biguanides

0.47

1.25

1.6

1.5

—

Congenital malformations of the respiratory system

2.41

1.24

4.2

6.5

—

Congenital malformations of the respiratory system, including avohilmo

2.41

1.24

4.2

6.5

—

Panic disorder

2.40

1.24

3.3

2.6

—

Acne vulgaris

2.22

1.24

5.5

4.6

—

Mood disorders, excluding more controls

1.64

1.23

2.0

2.3

—

Ischemic heart diseases

114

1.51

1.23

2.6

4.4

—

Other disorders originating in the perinatal period

2.19

1.22

7.8

7.4

—

Disorders of lacrimal system

1.90

1.22

2.9

3.2

—

Atopic conjunctivitis

2.64

1.21

8.8

5.9

—

Left ventricular outflow tract obstruction (LVOTO), broad definition

2.16

1.21

4.9

6.0

—

Iridocyclitis

2.16

1.21

1.5

3.2

—

Disorders of speech understanding and production

1.97

1.21

7.5

7.6

—

Fracture of femur

2.35

1.20

2.3

4.0

—

Injury, poisoning and certain other consequences of external causes

1.64

1.19

4.6

5.7

—

Stroke, excluding SAH

1.92

1.19

1.9

1.6

—

Premature rupture of membranes

0.00

1.19

0.0

1.5

—

Disorders of eyelid, lacrimal system and orbit

119

1.54

1.19

3.2

3.3

—

Aortic valve malfunction, age under 60 years

2.31

1.18

6.2

5.5

—

Paralytic ileus and intestinal obstruction

2.31

1.18

2.0

2.5

—

Transient ischemic attack

2.12

1.18

1.4

—

Diabetes medication

123

1.47

1.16

1.5

4.1

—

Other diseases of the digestive system

2.00

1.16

4.0

3.8

—

Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances

0.00

1.16

0.0

2.2

—

Non-selective monoamine reuptake inhibitors

0.00

1.16

0.0

1.2

—

Motor disorders

1.93

1.15

6.5

7.7

—

Allergic urticaria

2.50

1.15

8.0

6.3

—

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

2.00

1.11

3.1

7.3

—

GI-bleeding

1.96

1.11

4.0

3.7

—

Myopia

2.26

1.10

6.1

4.4

—

Calcific aortic valvular stenosis, operated

2.41

1.10

1.4

3.9

—

Calcific aortic valvular stenosis

2.41

1.10

1.4

3.9

—

Other and unspecified injuries of lower leg

2.38

1.09

3.8

5.1

—

Foreign body on external eye

2.38

1.09

3.6

2.2

—

Early onset COPD

2.38

1.09

1.0

2.4

—

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

1.73

1.08

6.9

5.2

—

Conotruncal defects

2.20

1.08

6.4

7.4

—

Adverse effects, not elsewhere classified

1.87

1.07

6.0

5.2

—

Diabetes, varying definitions

120

1.45

1.06

1.6

4.3

—

Sleep apnoea, including avohilmo

110

0.55

1.06

2.4

—

Organic, including symptomatic, mental disorders

2.14

1.05

1.3

1.5

—

Atopic dermatitis, strict definition with reimbursement

101

1.62

1.04

5.2

—

Supplementary factors related to causes of morbidity and mortality classified elsewhere

1.79

1.04

5.9

4.0

—

Contusion of other and unspecified parts of foot

2.28

1.03

3.4

6.6

—

Impacted maxillary molar

2.27

1.03

6.8

4.1

—

Spondyloarthritis

2.27

1.03

1.4

2.3

—

Disorders of conjunctiva

163

1.43

1.03

3.9

4.3

—

Congenital deformities of hip, including avohilmo

2.28

1.03

6.8

6.1

—

Congenital deformities of hip

2.28

1.03

6.8

6.1

—

Cholelithiasis, broad definition with cholecystitis

1.66

1.03

2.3

1.7

—

Myocardial infarction, without ST-elevation

2.26

1.01

1.2

1.3

—

Malignant neoplasm of digestive organs, including Hilmo

2.06

1.01

4.9

2.0

—

Malignant neoplasm of skin

2.06

1.01

1.0

1.7

—

Fracture of shoulder and upper arm

1.68

1.00

2.9

4.7

—

Colonic or urogenital fistula

2.00

1.00

4.0

1.8

—

Single delivery by forceps and vacuum extractor

0.00

0.99

0.0

1.5

—

Malignant neoplasm of breast, HER2-negative

0.00

0.99

0.0

1.2

—

Malignant neoplasm of breast

0.00

0.99

0.0

1.2

—

Malignant neoplasm of breast, HER2-negative, including Hilmo

0.00

0.99

0.0

1.2

—

Malignant neoplasm of breast, including Hilmo

0.00

0.99

0.0

1.2

—

Other disorders of ear

131

1.43

0.99

5.3

3.9

—

Mixed specific developmental disorders

1.82

0.99

6.6

7.4

—

Right ventricular outflow tract obstruction

2.19

0.98

7.0

7.3

—

Other symptoms and signs involving the nervous and musculoskeletal systems

1.67

0.97

4.1

4.9

—

Basal cell carcinoma

2.41

0.97

1.0

1.8

—

Conjunctivitis

159

1.42

0.95

4.1

4.4

—

COPD related to multimorbidity

2.30

0.95

1.0

1.5

—

Other and unspecified effects of external causes

1.69

0.95

5.8

4.8

—

All dysplastic lesions of the cervix uteri, vagina or vulva

2.17

0.92

1.3

1.2

—

Abnormalities of gait and mobility

2.14

0.91

3.3

5.3

—

Pacemaker

2.14

0.91

1.2

3.3

—

Other malignant neoplasms of skin (=non-melanoma skin cancer)

2.14

0.91

1.0

1.7

—

Angina pectoris

1.96

0.90

1.1

1.2

—

Ischaemic Stroke, excluding all haemorrhages

1.84

0.90

1.5

1.7

—

Fissure and fistula of anal and rectal regions

2.07

0.89

3.3

1.6

—

Malignant neoplasm of digestive organs

2.08

0.89

5.5

2.1

—

Personality disorders

1.91

0.88

2.0

1.8

—

Fall on same level involving ice and snow

105

0.48

0.88

3.0

3.1

—

Paracetamol or NSAID medication

0.52

0.88

2.8

5.9

—

Artrosis, including avohilmo

0.56

0.87

1.9

1.5

—

Pain in joint

1.56

0.87

2.4

4.1

—

Pre-eclampsia or poor fetal growth

1.99

0.86

1.0

1.5

—

Artificial joint operation, meniscal resection

0.57

0.86

1.4

1.6

—

Ovarian cyst

2.02

0.85

2.5

1.5

—

Other dorsopathies, not elsewhere classified

120

0.65

0.85

3.3

3.1

—

Depression

129

1.40

0.85

2.0

3.0

—

Mood [affective] disorders

129

1.39

0.85

2.1

3.0

—

Diseases of male genital organs

1.43

0.84

5.8

5.0

—

Mood disorders

129

1.39

0.84

2.1

3.0

—

Substance abuse, excluding more controls

1.67

0.83

1.5

1.8

—

Menorrhagia

1.97

0.83

2.2

1.5

—

Hypothyroidism, strict autoimmune, 3 medication purchases required

1.51

0.83

2.2

2.7

—

Dislocation, sprain and strain of joints and ligaments at ankle and foot level

112

0.53

0.82

6.7

4.2

—

Hypothyroidism, other/unspecified

1.45

0.81

2.4

3.0

—

Low back pain

102

0.60

0.81

2.1

2.3

—

Malignant neoplasm of breast, ER-positive, including Hilmo

0.00

0.81

0.0

1.3

—

Cardiac arrhythmias

1.48

0.80

2.8

4.6

—

Prolonged pregnancy

0.00

0.80

0.0

1.6

—

Other congenital malformations

1.72

0.79

4.7

7.2

—

Other sexually transmitted chlamydial diseases, including avohilmo

0.00

0.79

0.0

2.1

—

Allergic contact dermatitis

0.00

0.79

0.0

3.9

—

Neurological diseases

128

1.33

0.78

3.7

5.2

—

Female genital prolapse

2.32

0.78

2.2

1.3

—

Lower back pain or/and sciatica

125

0.65

0.78

1.8

2.3

—

Combinations of oral blood glucose lowering drugs

0.00

0.78

0.0

1.2

—

COPD, hospital admissions

1.80

0.77

1.0

2.1

—

Conductive and sensorineural hearing loss

1.44

0.77

5.6

3.2

—

COPD, early/later onset

1.80

0.77

1.0

2.1

—

Acne, including avohilmo

1.59

0.77

5.4

4.5

—

Congenital malformations of cardiac septa

1.62

0.76

3.3

8.0

—

Hypothyreosis and Thyroxine purchase for inclusion criteria

1.43

0.76

2.4

3.0

—

Cholelithiasis

1.57

0.75

2.3

1.7

—

Other arrhythmias

1.56

0.75

2.6

3.4

—

Hydrocele

2.08

0.74

5.6

5.0

—

Follicular cysts of skin and subcutaneous tissue

2.08

0.74

2.6

2.5

—

Dysphagia

2.08

0.74

5.0

2.5

—

Congenital malformations of eye, ear, face and neck

1.84

0.73

3.9

7.0

—

Injuries to the ankle and foot

164

1.35

0.73

4.7

3.9

—

Specific personality disorders

1.80

0.72

2.0

1.7

—

Falls/tendency to fall

163

0.74

0.71

4.8

4.1

—

Acute alcohol intoxication

1.75

0.71

2.3

2.6

—

Bacterial sepsis of newborn

1.94

0.71

10.4

7.0

—

Pain in throat and chest

1.40

0.71

3.5

3.2

—

Abnormal involuntary movements

1.92

0.70

2.0

3.7

—

Dyspnoea

133

1.36

0.70

1.8

4.1

—

Patent foramen ovale

1.86

0.68

4.8

7.5

—

Weight loss

1.85

0.68

8.6

5.6

—

Cervicalgia

1.85

0.68

1.0

2.1

—

Fracture of foot, except ankle

1.64

0.68

5.0

4.1

—

Abrasion of teeth

1.67

0.68

1.1

2.0

—

Other and unspecified urticaria

1.53

0.68

6.9

4.9

—

Fracture at wrist and hand level

0.55

0.67

2.6

4.6

—

Other disorders of penis

1.63

0.66

9.9

5.8

—

5-aminosalicylic acid

1.79

0.66

5.6

3.2

—

Benign paroxysmal vertigo

1.79

0.66

1.2

2.1

—

Dislocation, sprain and strain of joints and ligaments of knee

116

0.62

0.64

2.4

2.9

—

Undescended testicle

1.73

0.63

9.2

7.1

—

Other functional intestinal disorders

109

1.42

0.63

5.1

5.8

—

Sleep apnoea

105

0.66

0.63

2.5

2.4

—

Unspecific neurodegenerative disorder

0.00

0.61

0.0

1.1

—

Effects of foreign body entering through natural orifice

1.59

0.61

4.9

4.7

—

Fetus and newborn affected by maternal conditions that may be unrelated to present pregnancy

0.00

0.61

0.0

7.0

—

Type 2 diabetes, definitions combined, including avohilmo

0.61

0.60

1.6

1.8

—

Atopic dermatitis, strict definition

119

1.40

0.60

5.2

5.3

—

Other disorders of patella

0.00

0.59

0.0

1.8

—

Disorders of adult personality and behaviour

1.54

0.59

2.3

2.4

—

Malignant neoplasm of breast, HER-positive

0.00

0.59

0.0

1.3

—

Diverticular disease of intestine

1.56

0.58

1.3

—

Abnormal findings on examination of blood, without diagnosis

1.47

0.58

4.3

3.6

—

Carbimazole or st.post thyroidectomy, condition for graves disease

0.00

0.58

0.0

1.8

—

Cardiodefibrillation

0.00

0.58

0.0

2.3

—

Cholecystectomy

1.53

0.58

2.0

1.4

—

Vasomotor and allergic rhinitis

110

0.62

0.58

2.6

4.7

—

Urolithiasis

1.71

0.57

6.8

3.1

—

Childhood allergy (age < 16)

1.40

0.57

5.0

6.3

—

Injuries to the wrist and hand

168

1.26

0.57

1.7

4.4

—

Asthma, hospital admissions , main diagnosis only

175

1.29

0.57

4.0

4.2

—

Transport accidents

1.40

0.57

3.6

4.0

—

Disorders of the thyroid gland

108

1.32

0.54

2.3

2.8

—

Mental retardation, wide definition

1.53

0.53

5.7

7.9

—

Mental retardation

1.53

0.53

5.7

7.9

—

Lumbar disc prolapse

0.62

0.53

1.3

1.4

—

Acute alcohol intoxication, ICD10

1.54

0.53

2.3

2.6

—

Other chronic obstructive pulmonary disease

1.53

0.52

1.0

2.7

—

Transitory disorders of carbohydrate metabolism specific to fetus and newborn

1.43

0.52

6.0

7.7

—

Type of accident

1.43

0.52

6.8

3.8

—

Infections specific to the perinatal period

1.51

0.51

10.2

7.4

—

Injuries to the elbow and forearm

145

1.30

0.51

4.0

4.3

—

Transitory endocrine and metabolic disorders specific to fetus and newborn

1.40

0.51

6.0

7.6

—

Dorsopathies

138

0.77

0.51

4.4

3.7

—

Behavioural syndromes associated with physiological disturbances and physical factors

153

0.75

0.50

3.0

3.3

—

External causes of morbidity and mortality

1.31

0.50

4.6

5.0

—

Type 2 diabetes, definitions combined

0.64

0.50

1.6

1.8

—

Type 2 diabetes, strict (exclude DM1)

0.63

0.50

1.6

1.8

—

Type 1 diabetes, strict (exclude DM2)

1.38

0.50

2.3

6.8

—

Type 1 diabetes, definitions combined

1.38

0.50

2.3

6.8

—

Other congenital malformations, including avohilmo

1.49

0.49

4.7

6.5

—

Abnormalities of heart beat

1.54

0.48

3.1

2.7

—

IBD patients in KELA-register

1.46

0.46

4.3

3.5

—

Obesity, other/unspecified

1.46

0.46

1.7

2.7

—

Dorsalgia

118

0.76

0.45

2.9

3.0

—

Spondylopathies

0.69

0.45

1.2

2.0

—

Atopic dermatitis

131

1.28

0.44

4.8

4.3

—

Haemorrhagic and haematological disorders of fetus and newborn

1.43

0.44

5.2

7.5

—

Septal defects

1.42

0.44

3.5

7.8

—

Postmenopausal bleeding

0.00

0.43

0.0

1.3

—

Shoulder lesions

1.41

0.43

1.3

1.2

—

Calculus of kidney and ureter

1.61

0.43

8.0

3.1

—

Fracture of forearm

109

1.32

0.42

2.9

4.3

—

Excessive earwax

118

1.30

0.42

6.5

3.7

—

Congenital malformations of genital organs

1.42

0.42

7.5

6.8

—

Dipeptidyl peptidase 4 (DPP-4) inhibitors

1.39

0.42

1.4

1.2

—

N06DA Anticholinesterases

0.00

0.42

0.0

1.1

—

Use of anticholinesterases

0.00

0.42

0.0

1.1

—

Alzheimer disease, including avohilmo

0.00

0.42

0.0

1.1

—

Other symptoms and signs involving cognitive functions and awareness

1.39

0.42

1.8

2.2

—

Other disorders of veins

1.54

0.41

1.0

1.3

—

Liveborn infants according to place of birth

0.00

0.41

0.0

7.1

—

AV-block

0.00

0.41

0.0

4.1

—

Mental and behavioural disorders due to alcohol

1.38

0.41

1.8

2.3

—

Other chromosome abnormalities, not elsewhere classified

0.00

0.41

0.0

7.3

—

Other disorders of amniotic fluid and membranes

0.00

0.41

0.0

1.3

—

Congenital malformations of cardiac chambers and connections

0.00

0.41

0.0

7.9

—

Other eating disorders

0.00

0.41

0.0

6.1

—

Injury of muscle and tendon at hip and thigh level

0.00

0.41

0.0

4.6

—

Benign neoplasm of other and unspecified endocrine glands

0.00

0.41

0.0

1.9

—

Lichen planus, including avohilmo

0.00

0.41

0.0

1.3

—

FESS (DNB20)

0.00

0.41

0.0

2.4

—

Primary coxarthrosis, bilateral

0.00

0.41

0.0

1.3

—

1.34

0.41

1.9

2.4

—

Gonarthrosis,primary

0.68

0.41

1.0

1.2

—

Mandibular prognathia AND surgery (LeFortI or BSSO), including avohilmo

0.00

0.40

0.0

7.4

—

Enterobiasis, including avohilmo

0.00

0.40

0.0

7.4

—

Pathological/recurrent dislocation and subluxation of joint, not elsewhere classified

0.00

0.40

0.0

2.0

—

Ethmoidectomy

0.00

0.40

0.0

2.4

—

Benign neoplasm of colon, rectum, anus and anal canal

1.33

0.40

1.1

1.2

—

Other arthrosis

1.40

0.39

1.9

1.4

—

Irritable bowel syndrome

1.43

0.39

1.0

3.0

—

Caught, crushed, jammed or pinched in or between objects

0.00

0.39

0.0

5.6

—

Motorcycle rider injured in other and unspecified transport accidents

0.00

0.39

0.0

4.3

—

Hyperkinetic disorders (excl. ADHD)

1.41

0.38

6.6

6.9

—

Other external causes of accidental injury

114

0.79

0.38

4.3

4.4

—

Non-allergic asthma

1.39

0.38

6.0

6.7

—

Episodal and paroxysmal disorders

165

0.83

0.38

3.5

4.6

—

Meniscus derangement

1.41

0.37

1.9

1.1

—

Maternal care related to the fetus and amniotic cavity and possible delivery problems

0.65

0.37

1.0

1.6

—

Arthropathies

131

1.20

0.37

3.5

4.6

—

Sensorineural hearing loss

1.28

0.36

5.3

2.9

—

Sciatica+with lumbago

0.63

0.35

1.2

1.3

—

Superficial injury of wrist and hand

0.66

0.35

2.4

5.5

—

Allergic colitis

1.43

0.35

10.2

6.6

—

Leisure time condition

1.43

0.35

6.2

3.8

—

Atrial septal defect

1.42

0.35

2.8

7.3

—

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

120

0.72

0.35

4.3

4.4

—

Asthma/COPD (KELA code 203)

171

0.82

0.34

4.7

4.0

—

Open wound of wrist and hand

105

1.29

0.33

1.4

3.7

—

1.30

0.33

1.7

2.5

—

Allergic conjunctivitis

138

0.77

0.32

5.5

4.3

—

Benign neoplasm: Colon

1.28

0.32

1.2

—

Disorders of breast

1.34

0.31

1.9

1.8

—

Abnormal findings in secretions and smears from cervix uteri vagina vulva

1.32

0.31

2.3

1.3

—

Redundant prepuce, phimosis and paraphimosis

1.32

0.31

6.7

4.4

—

Inflammatory bowel disease, strict (require KELA)

1.32

0.30

4.3

3.6

—

Other inflammation of eyelid, including avohilmo

0.71

0.30

3.4

3.2

—

Other joint disorders

120

0.83

0.29

3.4

4.2

—

Diseases of inner ear

1.26

0.29

1.3

1.7

—

Constipation

155

0.83

0.29

3.8

4.6

—

Necrosis of pulp, including avohilmo

108

0.73

0.29

2.5

—

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

1.27

0.28

2.3

1.7

—

D07AA Corticosteroids, weak (group I)

1.31

0.27

4.5

6.5

—

Neonatal jaundice from other and unspecified causes

1.23

0.27

4.0

7.6

—

Mental and behavioural disorders due to alcohol, excluding acute intoxication

1.24

0.27

1.1

1.7

—

Other specific joint derangements/joint disorders

110

1.19

0.26

2.5

3.9

—

Inflammatory bowel disease

1.19

0.26

4.0

—

Focal epilepsy

1.25

0.25

4.7

5.3

—

Mental and behavioural disorders due to psychoactive substance use

1.24

0.24

1.7

2.5

—

Appendectomy

100

1.24

0.24

2.8

2.2

—

Selective serotonin reuptake inhibitors

122

0.85

0.24

2.4

3.2

—

Use of hypnotics and sedatives

113

1.16

0.23

1.8

3.2

—

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

1.25

0.22

5.6

3.1

—

Obesity due to excess calories

0.74

0.22

1.6

3.9

—

Alzheimer disease, excluding more controls

0.00

0.22

0.0

1.0

—

Alzheimer disease

0.00

0.22

0.0

1.1

—

Fetus and newborn affected by complications of placenta, cord and membranes

0.00

0.21

0.0

7.2

—

0.00

0.21

0.0

5.8

—

Congenital aortic valve stenosis

0.00

0.21

0.0

5.8

—

Complex cardiac defects

0.00

0.21

0.0

7.4

—

Disorder of the sleep-wake schedule

0.00

0.21

0.0

6.9

—

Toxic effect of contact with venomous animals

0.00

0.21

0.0

5.5

—

Maltreatment syndromes

0.00

0.21

0.0

4.1

—

Fibrosis and cirrhosis of liver

0.00

0.21

0.0

2.0

—

Graves disease, strict definition

0.00

0.21

0.0

1.7

—

Other and unspecified visual disturbances

0.00

0.21

0.0

3.2

—

Polycystic ovarian syndrome, broad definition

0.00

0.21

0.0

1.6

—

Psoriatic and enteropathic arthropathies

0.00

0.21

0.0

1.3

—

Lichen planus

0.00

0.21

0.0

1.4

—

Obstructed labour due to maternal pelvic abnormality

0.00

0.21

0.0

1.2

—

Familial hypercholesterolemia

0.00

0.21

0.0

4.4

—

Bicuspidal aortic valve syndrome

0.00

0.21

0.0

5.8

—

Other sexually transmitted chlamydial diseases

0.00

0.21

0.0

2.0

—

Abnormal findings on antenatal screening of mother

0.00

0.21

0.0

1.8

—

Nonalcoholic fatty liver disease

0.00

0.21

0.0

3.1

—

Metatarsalgia

0.00

0.21

0.0

2.7

—

Inflammatory diseases of prostate (prostatitis)

0.00

0.21

0.0

1.6

—

Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk

0.00

0.21

0.0

1.2

—

Seropositive rheumatoid arthritis, strict definition

0.00

0.21

0.0

1.2

—

Symptoms and signs involving speech and voice

1.16

0.21

2.6

2.7

—

Other congenital malformations of skull and face bones

0.00

0.21

0.0

5.5

—

Other and unspecified injuries of wrist and hand

0.00

0.21

0.0

7.2

—

Mental and behavioural disorders due to multiple drug use and use of multiple drugs and use of other psychoactive substances

0.00

0.21

0.0

2.5

—

Other enthesopathy of foot (+metatarsalgia)

0.00

0.21

0.0

2.5

—

Cervicocranial syndrome

0.00

0.21

0.0

1.6

—

Diabetes mellitus in pregnancy

1.27

0.20

1.2

1.5

—

Appendicitis, broad definition

113

1.19

0.20

2.2

—

Monosomies and deletions from the autosomes, not elsewhere classified

0.00

0.20

0.0

6.4

—

COPD

1.25

0.20

1.0

2.4

—

Major anomalies of jaw size

0.00

0.20

0.0

6.2

—

Burn and corrosion of wrist and hand

0.00

0.20

0.0

4.5

—

Struck by thrown, projected or falling objec

0.00

0.20

0.0

5.9

—

Accidental poisoning by and exposure to other and unspecified drugs, medicaments and biological substances

0.00

0.20

0.0

4.1

—

Injury of unspecified body region

0.00

0.20

0.0

4.8

—

Recurrent dislocation and subluxation of joint

0.00

0.20

0.0

2.1

—

Radiculopathy

0.00

0.20

0.0

1.3

—

Diseases of liver

1.25

0.20

2.2

2.9

—

Other complications of labour and delivery, not elsewhere classified

0.00

0.20

0.0

1.4

—

Diseases of appendix

113

1.19

0.20

2.2

—

Fracture of lower leg, including ankle

1.21

0.19

3.8

3.5

—

Ulcerative colitis

1.18

0.19

5.0

3.8

—

Injuries to the shoulder and upper arm

152

0.86

0.19

2.6

3.6

—

Migraine with aura

1.15

0.19

5.5

3.5

—

Fall on same level

178

0.90

0.19

4.6

4.1

—

Congenital malformations of great arteries

1.13

0.18

4.5

8.2

—

Obesity related asthma

1.13

0.18

2.5

3.2

—

Accidents

114

0.88

0.17

4.1

4.4

—

Dermatitis due to ingested food

0.75

0.17

4.4

7.2

—

Superficial injury of lower leg

0.76

0.17

2.0

4.1

—

Symptoms and signs involving cognition, perception, emotional state and behaviour

130

1.13

0.17

2.3

3.0

—

Rotator cuff syndrome

1.15

0.16

1.1

1.2

—

Intracranial injury

141

0.86

0.16

4.1

4.7

—

Epilepsy

1.19

0.15

4.5

5.9

—

Temporomandibular joint disorders, including avohilmo

1.15

0.15

1.7

2.5

—

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

0.81

0.13

3.9

2.7

—

Substance abuse

1.16

0.13

1.5

2.5

—

Reimbursement for rheumatic diseases

1.16

0.12

4.3

4.0

—

Exposure to other specified factors

180

1.10

0.12

2.3

4.2

—

Striking against or struck by other objects

114

1.14

0.11

2.7

5.0

—

Other antidepressants

102

0.90

0.11

2.0

2.4

—

Alcohol use disorder, Swedish definition

1.16

0.11

1.5

1.9

—

Injuries to the head

177

1.07

0.10

3.3

4.1

—

Unspecified fall

133

0.89

0.10

5.6

5.2

—

Asthma, including avohilmo

177

0.93

0.10

3.8

4.0

—

Chronic apical periodontitis

113

1.09

0.10

1.4

3.2

—

Fall on and from stairs and steps

1.14

0.10

5.2

3.8

—

Exclusions for E4_PCOS_CONSORTIUM

120

1.09

0.09

5.3

4.6

—

Dizziness and giddiness

0.88

0.09

1.9

2.7

—

Spontaneous abortion

1.05

0.09

1.4

1.5

—

Disorders of vestibular function (Vertigo)

1.06

0.09

1.2

1.8

—

Internal derangement of knee

1.12

0.09

2.0

2.4

—

Other (not insulin) diabetes medications

0.88

0.09

1.6

1.7

—

Acute appendicitis

108

1.12

0.08

2.2

2.3

—

Other chronic obstructive pulmonary disease, including avohilmo

1.05

0.08

1.0

2.1

—

Dental pulpitis, including avohilmo

132

0.92

0.08

1.5

3.0

—

Focal epilepsy, mode (most common among epilepsy diagnosis)

0.82

0.08

3.2

5.1

—

Pedal cyclist injured in transport accident

0.81

0.08

6.4

4.4

—

Carpal tunnel syndrome

1.10

0.08

1.3

—

Deforming dorsopathies

1.09

0.08

2.7

4.4

—

Focal epilepsy, strict definition

1.08

0.08

4.4

5.1

—

Obesity and other hyperalimentation

115

0.90

0.07

1.7

3.5

—

Open wound of head

138

1.09

0.07

4.8

4.7

—

Arthrosis

0.86

0.07

1.9

1.5

—

Gonarthrosis [arthrosis of knee](FG)

0.87

0.07

1.0

1.2

—

Periapical abscess

0.89

0.06

1.8

3.6

—

Injuries to the knee and lower leg

159

1.05

0.06

2.9

4.0

—

Obesity

114

0.91

0.06

1.7

3.5

—

Asthma (diagnoses ohter than nonallergic)

176

1.05

0.05

4.1

4.3

—

Benzodiazepine use

121

1.06

0.04

1.9

2.3

—

Migraine

102

1.07

0.03

3.9

4.3

—

Acute appendicitis, no complications

1.08

0.02

2.4

2.1

—

Other nutritional deficiencies

121

1.06

0.02

2.0

3.4

—

Depression or dysthymia

1.05

0.00

3.0

2.8

—

Concussion

107

1.01

0.00

3.8

5.1

—

Other diseases of upper respiratory tract

145

1.01

0.00

5.2

3.8

—

Diseases of pulp and periapical tissues, including avohilmo

142

0.98

0.00

2.4

4.7

—

Intracranial trauma

109

0.99

0.00

3.5

5.3

—

Chronic lower respiratory diseases

173

1.00

0.00

3.6

4.1

—

Dermatophytosis, including avohilmo

122

1.04

0.00

2.8

3.1

—

L02BB Anti-androgens

0.00

0.0

1.0

—

Other osteochondrodysplasias

0.00

0.0

5.6

—

Abnormal spermatozoa

0.00

0.0

1.4

—

Infections of genitourinary tract in pregnancy

0.00

0.0

1.1

—

Single ventricle heart

0.00

0.0

7.7

—

0.00

0.0

1.4

—

Rubella [German measles]

0.00

0.0

1.0

—

Sequelae of injuries of lower limb

0.00

0.0

1.9

—

L04AC Interleukin inhibitors

0.00

0.0

4.3

—

Malignant neoplasm of adrenal gland, including Hilmo

0.00

0.0

7.6

—

Benign neoplasm: Pituitary gland, craniopharyngeal duct

0.00

0.0

3.3

—

Other respiratory conditions originating in the perinatal period

0.00

0.0

5.5

—

L02BA Anti-estrogens

0.00

0.0

1.2

—

Microcephaly

0.00

0.0

5.0

—

Other peripheral vascular diseases

0.00

0.0

1.7

—

Macrocephaly

0.00

0.0

6.6

—

Dislocation, sprain and strain of joints and ligaments at wrist and hand level

0.95

0.00

1.4

4.4

—

Parkinson's disease, strict definition, excluding more controls

0.00

0.0

1.0

—

Vestibular neuronitis

0.00

0.0

1.0

—

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

0.00

0.0

1.0

—

Congenital malformations of lung, including avohilmo

0.00

0.0

6.4

—

Other congenital malformations of face and neck

0.00

0.0

3.9

—

Malignant neoplasm of endocrine gland, including Hilmo

0.00

0.0

4.7

—

Pathological resorption of teeth

0.00

0.0

3.8

—

Abnormal pulmonary venous return

0.00

0.0

6.8

—

Other headache syndromes

0.92

-0.00

1.0

2.9

—

Alcohol use disorder, ICD-based

0.94

-0.00

1.2

1.7

—

Benign neoplasm of major salivary glands

0.00

-0.00

0.0

1.0

—

Pediculosis, acariasis and other infestations, including avohilmo

0.88

-0.00

5.3

4.6

—

Clubfoot

0.00

-0.00

0.0

5.0

—

Cirrhosis of liver, NAS

0.00

-0.00

0.0

2.2

—

Aortic hypoplasia

0.00

-0.00

0.0

5.0

—

Scabies, including avohilmo

0.97

-0.00

5.3

4.9

—

Malignant neoplasm of breast, ER-negative, including Hilmo

0.00

-0.00

0.0

1.2

—

Alzheimer’s disease (Late onset), excluding more controls

0.00

-0.00

0.0

1.0

—

Systemic atrophies primarily affecting the central nervous system

0.00

-0.00

0.0

7.0

—

Sudden idiopathic hearing loss

0.00

-0.00

0.0

1.4

—

Transient global amnesia

0.00

-0.00

0.0

1.0

—

Chronic sinusitis

1.00

-0.00

5.0

2.1

—

Migraine without aura

0.94

-0.00

3.8

5.0

—

Muscular dystrophy

0.00

-0.00

0.0

7.7

—

Parkinson's disease

0.00

-0.00

0.0

1.0

—

Maxillary prognathism

0.00

-0.00

0.0

5.4

—

Other disorders of pigmentation

0.00

-0.00

0.0

5.0

—

Other bursopathies

0.00

-0.00

0.0

2.3

—

Synovial cyst of popliteal space [Baker]

0.00

-0.00

0.0

2.4

—

Fatigue fracture of vertebra

0.00

-0.00

0.0

6.3

—

Psoriatic arthropathies, ICD10

0.00

-0.00

0.0

1.4

—

Pregnancy with abortive outcome

0.91

-0.00

1.3

1.7

—

Leiomyoma of uterus

0.99

-0.00

1.0

1.3

—

Failed induction of labour

0.00

-0.00

0.0

1.7

—

Other obstructed labour

0.00

-0.00

0.0

1.3

—

Other perinatal digestive system disorders

0.00

-0.00

0.0

7.4

—

Raynaud syndrome

0.00

-0.00

0.0

1.9

—

Other osteochondrodysplasias, including avohilmo

0.00

-0.00

0.0

5.6

—

Other perinatal haematological disorders

0.00

-0.00

0.0

6.1

—

Rheumatism, unspecified

0.00

-0.00

0.0

1.0

—

Phakomatoses, not elsewhere classified

0.00

-0.00

0.0

7.0

—

Use of levodopa decarboxylase inhibitor

0.00

-0.00

0.0

1.0

—

Congenital malformations of great veins

0.00

-0.00

0.0

6.7

—

Gonarthrosis

0.92

-0.00

1.0

1.1

—

Other psoriatic arthropathies

0.00

-0.00

0.0

1.4

—

Ebstein's anomaly

0.00

-0.00

0.0

6.4

—

Ventricular septal defect, a heart condition

1.02

-0.00

4.0

7.2

—

Pulmonary artery stenosis

0.00

-0.00

0.0

4.2

—

Craniosynostosis EXCLUDE syndromes

0.00

-0.00

0.0

5.0

—

Other obstetric trauma

0.00

-0.00

0.0

1.1

—

Amiodarone users

0.00

-0.00

0.0

1.5

—

Congenital malformations of lung

0.00

-0.00

0.0

6.4

—

Other diseases of blood and blood-forming organs

0.00

-0.00

0.0

3.6

—

Down's syndrome

0.00

-0.00

0.0

6.0

—

Operations 1 for CAVS

0.00

-0.00

0.0

9.0

—

Cervical disc disorders

0.98

-0.00

1.0

1.2

—

Infliximab

0.00

-0.00

0.0

3.3

—

Injuries to the abdomen, lower back, lumbar spine and pelvis

0.96

-0.00

1.3

4.3

—

Trisomy 21 (Down syndrome) due to meiotic nondisjunction

0.00

-0.00

0.0

6.0

—

Benign neoplasm of middle ear and respiratory system

0.00

-0.00

0.0

2.7

—

Fetus and newborn affected by maternal factors and by complications of pregnancy, labour and delivery

0.99

-0.00

8.7

7.5

—

Autoimmune hyperthyroidism

0.00

-0.00

0.0

2.4

—

Congenital malformation syndromes predominantly affecting facial appearance

0.00

-0.00

0.0

4.7

—

Colorectal adenocarcinoma

0.00

-0.00

0.0

1.7

—

Use of memantine

0.00

-0.00

0.0

1.1

—

Memory loss

0.00

-0.00

0.0

1.0

—

Alzheimer’s disease, strict definition

0.00

-0.00

0.0

1.1

—

Other lack of coordination

0.00

-0.00

0.0

5.8

—

Lactose intolerance

0.00

-0.00

0.0

5.7

—

Malignant neoplasm of breast, HER-negative

0.00

-0.00

0.0

1.2

—

Digestive system disorders of fetus and newborn

0.00

-0.00

0.0

6.7

—

Parkinson's disease, strict definition

0.00

-0.00

0.0

1.0

—

Malignant neoplasm of endocrine gland

0.00

-0.00

0.0

4.4

—

Use of donepezil

0.00

-0.00

0.0

1.1

—

Alzheimer’s disease (Late onset)

0.00

-0.00

0.0

1.1

—

Burns classified according to extent of body surface involved

0.00

-0.00

0.0

4.5

—

Suppurative and necrotic conditions of lower respiratory tract

0.00

-0.00

0.0

3.8

—

Lactose intolerance, other/unspecified

0.00

-0.00

0.0

5.7

—

Injury of intra-abdominal organs

0.00

-0.00

0.0

5.3

—

Alzheimer’s disease (Atypical or mixed)

0.00

-0.00

0.0

1.0

—

Dislocation, sprain and strain of joints and ligaments of lumbar spine and pelvis

0.00

-0.00

0.0

4.5

—

Open wound of abdomen, lower back and pelvis

0.00

-0.00

0.0

6.1

—

Benign neoplasm of eye and adnexa

0.00

-0.00

0.0

1.9

—

Other and unspecified injuries of shoulder and upper arm

0.00

-0.00

0.0

2.0

—

Residual foreign body in soft tissue

0.00

-0.00

0.0

5.0

—

Congenital iodine-deficiency syndrome/hypothyroidism

0.00

-0.00

0.0

5.6

—

Other symptoms and signs involving general sensations and perceptions

0.00

-0.00

0.0

3.2

—

Certain zoonotic bacterial diseases, including avohilmo

0.00

-0.00

0.0

3.8

—

Parkinson's disease, excluding more controls

0.00

-0.00

0.0

1.0

—

Open wound of hip and thigh

0.00

-0.00

0.0

4.1

—

Use of other anti-dementia drugs

0.00

-0.00

0.0

1.1

—

Use of rivastigmine

0.00

-0.00

0.0

1.0

—

Benign neoplasm: Skin of scalp and neck

0.00

-0.00

0.0

6.3

—

Thiazolidinediones

0.00

-0.00

0.0

1.5

—

Injuries to the hip and thigh

1.01

-0.00

2.3

3.9

—

Other puerperal infections

0.00

-0.00

0.0

1.1

—

Contact with other hot metals

0.00

-0.00

0.0

4.6

—

Benign lipomatous neoplasm of other sites/unspecified

0.00

-0.00

0.0

1.0

—

Rubella [German measles], including avohilmo

0.00

-0.00

0.0

1.0

—

Spermatocele

0.00

-0.00

0.0

2.6

—

Foreign body or object entering through skin

0.00

-0.00

0.0

3.1

—

Antepartum haemorrhage, not elsewhere classified

0.00

-0.00

0.0

1.2

—

Other pulmonary heart/vessel disease

0.00

-0.00

0.0

4.5

—

Intentional self-harm by sharp object

0.00

-0.00

0.0

4.0

—

Other fall from one level to another

1.00

-0.00

2.6

5.9

—

Motorcycle rider injured in noncollision transport accidents

0.00

-0.00

0.0

3.5

—

Unspecified event, undetermined intent

0.00

-0.00

0.0

5.8

—

Burn and corrosion of trunk

0.00

-0.00

0.0

6.8

—

Female infertility, associated with anovulation

0.00

-0.00

0.0

1.0

—

Benign mammary dysplasia

0.00

-0.00

0.0

1.8

—

Psoriatic arthropathies

0.00

-0.00

0.0

1.3

—

Polymyalgia rheumatica

0.00

-0.00

0.0

1.2

—

Congenital hypothyroidism without goiter

0.00

-0.00

0.0

5.6

—

Other specified diseases with participation of lymphoreticular and reticulohistiocytic tissue

0.00

-0.00

0.0

7.0

—

False labour

0.94

-0.00

1.0

1.6

—

Medical abortion

1.02

-0.00

1.6

1.7

—

Constitutional tall stature

0.00

-0.00

0.0

4.7

—

Entropion and trichiasis of eyelid

0.00

-0.00

0.0

2.2

—

Wet age-related macular degeneration

0.00

-0.00

0.0

1.0

—

Parkinson's disease, including avohilmo

0.00

-0.00

0.0

1.0

—

Emphysema

0.00

-0.00

0.0

1.2

—

Gestational diabetes (for exclusion)

1.01

-0.00

1.2

1.5

—

Disorder of visual pathways, unspecified

0.00

-0.00

0.0

7.0

—

Gender identity disorders

0.00

-0.00

0.0

4.7

—

Recurrent or chronic depression

0.94

-0.00

1.6

1.9

—

malignant neoplasm of female genital organs

0.00

-0.00

0.0

2.5

—

Dementia in Alzheimer disease

0.00

-0.00

0.0

1.0

—

Alcoholic liver disease

0.00

-0.00

0.0

1.4

—

Ovarian dysfunction

0.00

-0.00

0.0

1.8

—

Colon adenocarcinoma, helper endpoint

0.00

-0.00

0.0

1.0

—

Lichen simplex chronicus and prurigo

0.00

-0.00

0.0

3.6

—

Ulcerative proctitis

0.00

-0.00

0.0

3.5

—

Secondary right heart disease

0.00

-0.00

0.0

5.4

—

Type1 diabetes, definitions combined, early onset

0.93

-0.00

3.0

6.8

—

Radial styloid tenosynovitis [de Quervain]

0.00

-0.00

0.0

1.0

—

Varicose veins of other sites

0.00

-0.00

0.0

3.2

—

Other/unspecified rheumatoid arthritis

0.00

-0.00

0.0

1.0

—

Unspecified jaundice

0.00

-0.00

0.0

5.7

—

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS